Crataegeus oxyacantha Linn.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Rosaceae. |
| Habitat | British and European hedge plant, met with in the temperate Himalayas of Kashmir and Himachal Pradesh at an altitude of 1,800–3,000 m. (The plant does not thrive in the plains of India.) |
| English | English Hawthorn. |
| Folk | Ring, Ringo, Pingyat, Phindak, Ban Sanjli (Punjab hills). |
| Action | Coronary vasodilator (strengthens heart muscle without increasing the beat in coronary arteries), antispasmodic, antihypertensive, sedative to nervous system, diuretic. |
| Key Application | In cases of cardiac insufficiency Stage II as defined by NYHA (New York Heart Association). An improvement of subjective findings as well as an increase in cardiac work tolerance, a decrease in pressure/heart rate product, an increase in the ejection fraction and a rise in the anaerobic threshold have been established in human pharmacological studies. (German Commission E, WHO.) |
| Taxonomic Cohort | Genus Crataegeus (1 documented species); Family Rosaceae (36 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Crataegeus oxyacantha (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Rosaceae (primary family classification: Rosaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: British and European hedge plant, met with in the temperate Himalayas of Kashmir and Himachal Pradesh at an altitude of 1,800–3,000 m. (The plant does not thrive in the plains of India.).
Across classical and vernacular Indian systems of medicine, Crataegeus oxyacantha is recognized under distinct polyglot nomenclature: in English botanical and trade usage as English Hawthorn; in regional Indian folk and vernacular ethnobotany as Ring, Ringo, Pingyat, Phindak, Ban Sanjli (Punjab hills). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Crataegeus oxyacantha are: Coronary vasodilator (strengthens heart muscle without increasing the beat in coronary arteries), antispasmodic, antihypertensive, sedative to nervous system, diuretic. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias. Furthermore, international and national regulatory monographs highlight its validated key clinical application: In cases of cardiac insufficiency Stage II as defined by NYHA (New York Heart Association). An improvement of subjective findings as well as an increase in cardiac work tolerance, a decrease in pressure/heart rate product, an increase in the ejection fraction and a rise in the anaerobic threshold have been established in human pharmacological studies. (German Commission E, WHO.).
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Crataegeus oxyacantha establish the following evidence base: The active principles include oligomeric procyanidins and flavonoids. The drug is official in Homoeopathic Pharmacopoeia of India. Contraindicated in low blood pressure, chest pain, bleeding disorders. The herb may interfere with therapeutic effect of cardiac drugs. (Sharon M. Herr.) Preparations based on hydroalcoholic extracts of Crataegus monogyna or C. laevigata are used as Hawthorn in the Western herbal.
4. Comparative Genus & Family Pharmacognosy
Within Indian medicinal flora, Crataegeus oxyacantha stands as a distinct representative of the genus Crataegeus. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.
At the family level, Rosaceae encompasses 36 documented medicinal species (1.98% of the 1,814-species flora). Other representative medicinal members of Rosaceae include: Amygdalus communis (Vaataama), Amygdalus persica (Aaruka), Brayera anthelmintica (Cusso), Crataegus crenulata (Ghingaaru), Cydonia oblonga (Amritaphala). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 36 medicinal species of family Rosaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Crataegeus oxyacantha follow the plant-part modalities specified under its therapeutic action (Coronary vasodilator (strengthens heart muscle without increasing the beat in coronary arteries), antispasmodic, antihypertensive, sedative to nervous system, diuretic), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Crataegeus oxyacantha integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.